Johns Hopkins ABX Guide
Grepafloxacin
INDICATIONS
FDA
FDA
- No longer manufactured for U.S. or global markets due to QTc prolongation, withdrawn 1999 (due to cardiac events and sudden death)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Acute exacerbation of chronic bronchitis
- Chlamydial infection
- Community-acquired pneumonia
- Gonorrhea
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: February 3, 2021
Citation
Avdic, Edina. "Grepafloxacin." Johns Hopkins ABX Guide, The Johns Hopkins University, 2021. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540250/5/Grepafloxacin.
Avdic E. Grepafloxacin. Johns Hopkins ABX Guide. The Johns Hopkins University; 2021. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540250/5/Grepafloxacin. Accessed December 12, 2024.
Avdic, E. (2021). Grepafloxacin. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540250/5/Grepafloxacin
Avdic E. Grepafloxacin [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2021. [cited 2024 December 12]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540250/5/Grepafloxacin.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Grepafloxacin
ID - 540250
A1 - Avdic,Edina,Pharm.D.
Y1 - 2021/02/03/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540250/5/Grepafloxacin
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
